Özge Atılgan Karakulak Spoke at the Pharma Biotech Patent Litigation Europe Summit
Özge Atılgan Karakulak, partner in our Life Sciences and Patents and Utility Models practices, spoke at the Pharma Biotech Patent Litigation Europe Summit in Amsterdam, which took place on January 21-22, 2025.
She spoke at the session titled “Bolar Exemption Safe Harbor Update Across Europe and the USA."
The summit provides critical insights, including analyses of the first UPC decisions on the merits, cross-border case law, and refined litigation strategies. Key sessions address patent litigation strategies, second medical uses, SPCs, antitrust considerations, and patentability issues, offering a comprehensive view of regulatory changes. This event is an opportunity to stay updated on European Commission reforms and recent case law, with specific updates on the Bolar Exemption and unitary SPC review.
For more information, click here.